Atlas Trials

Study Evaluating Efficacy and Safety of Froniglutide (PF1801) in Patients With Idiopathic Inflammatory Myopathy

Clinical trial NCT05833711 · UNKNOWN

Trial details

NCT number
NCT05833711
Sponsor
Immunoforge Co. Ltd.
Status
UNKNOWN
Phase
Phase 2
Study type
INTERVENTIONAL
DermatomyositisPolymyositisIdiopathic Inflammatory Myopathies
Start date
2023-09-05
Primary completion
2025-03-01
Enrollment
39

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.